share_log
Moomoo 24/7 ·  04/22 09:04

ACADIA Pharmaceuticals Announces Trofinetide New Drug Submission for Treatment of Rett Syndrome Has Been Accepted for Filing and Priority Review by Health Canada

ACADIA Pharmicals宣佈,用於治療雷特綜合徵的Trofinetide新藥已被加拿大衛生部接受申請和優先審查

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論